title: [News in diabetology 2015].
abstract: The year 2015 was punctuated by numerous events in diabetology. First, the ADA/EASD guidelines have been updated. The pharmacological panel for type 2 diabetes treatment saw the arrival of different new molecules. Two new basal insulins were also approved. Also, cardiovascular safety trials have been published regarding recent antidiabetic drugs. A new insulin pump than can be coupled with a glucosensor was released. Finally, a new unexpected complication of SGLT2 inhibitors treatment was reported, the euglycemic keto-acidosis.
authors.forename: François R
authors.initials: FR
authors.lastname: Jornayvaz
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D061385:Insulins / Q000008:administration & dosage; D017410:Practice Guidelines as Topic
chemical_list: D007004:Hypoglycemic Agents; D061385:Insulins